Hospital La Paz

Running trials

• Recruiting

  Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer

  2025-521460-36-00· Phase 4· Source

• Active, not recruiting

  Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

  NCT07299097· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Source

• Recruiting

  Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

  NCT06701825· Phase 4· Source

• Recruiting

  Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

  NCT06908785· Source

• Recruiting

  A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  NCT05967689· Phase 2· Source

• Recruiting

  Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry

  NCT05673681· Source

• Active, not recruiting

  Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device

  NCT06286956· Source

• Recruiting

  ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

  NCT03563417· Source

• Enrolling by invitation

  EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

  NCT02699736· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Endometrial cancer1 recruiting
• Hepatitis B1 recruiting
• Hepatitis C1 recruiting
• HIV1 recruiting
• Liver cirrhosis1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

  NCT05913193· Source

• Recruiting

  sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

  NCT04766866· Source

• Completed

  Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

  NCT06031038· Source

• Completed

  DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)

  NCT04014075· Phase 2· Source

• Completed

  Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)

  NCT04107727· Phase 2· Source

• Completed

  Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M

  NCT03133546· Phase 2· Source

• Completed

  ODYSSEY (PENTA 20)

  NCT02259127· Phase 2/3· Source

• Completed

  An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)

  NCT01853826· Phase 3· Source